NasdaqCM - Nasdaq Real Time Price
USD
Inovio Pharmaceuticals, Inc. (INO)
0.7101
-0.0617
(-7.99%)
As of 11:58:30 AM EDT. Market Open.
Trade INO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutINOVIO’s central catalyst is the FDA’s October 30, 2026, target decisionon INO-3107 for recurrent respiratory papillomatosis. The company has reported supportive surgery-reduction data and a cash runway into early 2027, but accelerated-approval eligibility and confirmatory-trial requirements remain unresolved.[2][3][4] INO is down 5.04% in the current regular sessionas of October 30, 2026.
No news stories available
